KBC Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-596
| Closed | -$59K | – | 1728 |
|
|
2025
Q2 | $59K | Sell |
596
-332
| -36% | -$31.4K | ﹤0.01% | 1517 |
|
|
2025
Q1 | $86K | Sell |
928
-230
| -20% | -$21.2K | ﹤0.01% | 1568 |
|
|
2024
Q4 | $105K | Buy |
1,158
+503
| +77% | +$46.2K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $63K | Buy |
+655
| New | +$63.9K | ﹤0.01% | 1591 |
|
|
2024
Q2 | – | Sell |
-436
| Closed | -$40K | – | 1847 |
|
|
2024
Q1 | $40K | Hold |
436
| – | – | ﹤0.01% | 1662 |
|
|
2023
Q4 | $41K | Sell |
436
-151
| -26% | -$14.1K | ﹤0.01% | 1656 |
|
|
2023
Q3 | $55K | Buy |
+587
| New | +$54.2K | ﹤0.01% | 1366 |
|
|
2020
Q1 | – | Sell |
-4,742
| Closed | -$792K | – | 1285 |
|
|
2019
Q4 | $792K | Sell |
4,742
-4,369
| -48% | -$650K | 0.01% | 967 |
|
|
2019
Q3 | $1.19M | Sell |
9,111
-4,206
| -32% | -$548K | 0.01% | 810 |
|
|
2019
Q2 | $1.62M | Sell |
13,317
-983
| -7% | -$117K | 0.01% | 674 |
|
|
2019
Q1 | $1.76M | Sell |
14,300
-9,723
| -40% | -$1.22M | 0.01% | 649 |
|
|
2018
Q4 | $2.81M | Sell |
24,023
-23,435
| -49% | -$2.76M | 0.03% | 456 |
|
|
2018
Q3 | $5.93M | Buy |
47,458
+28,861
| +155% | +$3.19M | 0.04% | 394 |
|
|
2018
Q2 | $1.59M | Sell |
18,597
-24,827
| -57% | -$1.82M | 0.01% | 663 |
|
|
2018
Q1 | $2.62M | Hold |
43,424
| – | – | 0.02% | 522 |
|
|
2017
Q4 | $2.29M | Hold |
43,424
| – | – | 0.02% | 570 |
|
|
2017
Q3 | $2.43M | Hold |
43,424
| – | – | 0.02% | 563 |
|
|
2017
Q2 | $2.73M | Sell |
43,424
-52,043
| -55% | -$3.03M | 0.03% | 514 |
|
|
2017
Q1 | $4.88M | Sell |
95,467
-10,724
| -10% | -$511K | 0.04% | 415 |
|
|
2016
Q4 | $4.53M | Buy |
106,191
+19,187
| +22% | +$816K | 0.04% | 416 |
|
|
2016
Q3 | $4.13M | Buy |
87,004
+19,135
| +28% | +$955K | 0.05% | 386 |
|
|
2016
Q2 | $3.43M | Buy |
67,869
+44,111
| +186% | +$2.23M | 0.05% | 403 |
|
|
2016
Q1 | $1.15M | Sell |
23,758
-10,945
| -32% | -$422K | 0.02% | 615 |
|
|
2015
Q4 | $1.36M | Buy |
34,703
+12,346
| +55% | +$494K | 0.03% | 549 |
|
|
2015
Q3 | $849K | Sell |
22,357
-23,903
| -52% | -$1.01M | 0.02% | 634 |
|
|
2015
Q2 | $1.84M | Sell |
46,260
-14,987
| -24% | -$467K | 0.02% | 583 |
|
|
2015
Q1 | $1.64M | Buy |
61,247
+27,563
| +82% | +$778K | 0.02% | 602 |
|
|
2014
Q4 | $989K | Buy |
+33,684
| New | +$832K | 0.01% | 752 |
|
Other funds holding AMED
IA
MCI
HNB
KBC Group's AMED Position: Q3 2025 in Review
KBC Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 596 shares — an estimated $59K sold.
KBC Group first reported a position in AMED in Q4 2014 and held it in 28 quarters. The position peaked at $5.93M in Q3 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- KBC Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- KBC Group sold 596 Amedisys shares in Q3 2025, an estimated $59K.
- KBC Group first reported a position in Amedisys in Q4 2014 and held it in 28 quarters.
- KBC Group's Amedisys position peaked at $5.93M in Q3 2018.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on KBC Group's 13F filing for Q3 2025, filed 20 Jan 2026.